• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

温度响应型纳米颗粒能够特异性结合人血浆中的载脂蛋白。

Temperature-Responsive Nanoparticles Enable Specific Binding of Apolipoproteins from Human Plasma.

机构信息

Max Planck Institute for Polymer Research, Ackermannweg 10, 55128, Mainz, Germany.

Max Planck-VISTEC Partner Laboratory for Sustainable Materials, Vidyasirimedhi Institute of Science and Technology (VISTEC), Rayong, 21210, Thailand.

出版信息

Small. 2022 Jan;18(3):e2103138. doi: 10.1002/smll.202103138. Epub 2021 Nov 10.

DOI:10.1002/smll.202103138
PMID:34761508
Abstract

Apolipoproteins are an important class of proteins because they provide a so-called stealth effect to nanoparticles. The stealth effect on nanocarriers leads to a reduced unspecific uptake into immune cells and thereby to a prolonged blood circulation time. Herein, a novel strategy to bind apolipoproteins specifically on nanoparticles by adjusting the temperature during their incubation in human plasma is presented. This specific binding, in turn, allows a control of the stealth behavior of the nanoparticles. Nanoparticles with a well-defined poly(N-isopropylacrylamide) shell are prepared, displaying a reversible change of hydrophobicity at a temperature around 32 °C. It is shown by label-free quantitative liquid chromatography-mass spectrometry that the nanoparticles are largely enriched with apolipoprotein J (clusterin) at 25 °C while they are enriched with apolipoprotein A1 and apolipoprotein E at 37 °C. The temperature-dependent protein binding is found to significantly influence the uptake of the nanoparticles by RAW264.7 and HeLa cells. The findings imply that the functionalization of nanoparticles with temperature-responsive materials is a suitable method for imparting stealth properties to nanocarriers for drug-delivery.

摘要

载脂蛋白是一类重要的蛋白质,因为它们为纳米颗粒提供了所谓的隐身效应。纳米载体的隐身效应导致免疫细胞的非特异性摄取减少,从而延长血液循环时间。本文提出了一种通过在人血浆中孵育纳米载体时调节温度来特异性结合载脂蛋白的新策略。这种特异性结合反过来又可以控制纳米颗粒的隐身行为。制备了具有明确的聚(N-异丙基丙烯酰胺)壳的纳米颗粒,在约 32°C 时表现出可逆的疏水性变化。通过无标记定量液相色谱-质谱法表明,在 25°C 时,纳米颗粒主要富含载脂蛋白 J(簇蛋白),而在 37°C 时富含载脂蛋白 A1 和载脂蛋白 E。发现蛋白质的温度依赖性结合会显著影响 RAW264.7 和 HeLa 细胞对纳米颗粒的摄取。这些发现表明,用温度响应材料对纳米颗粒进行功能化是赋予纳米载体药物递送隐身性能的一种合适方法。

相似文献

1
Temperature-Responsive Nanoparticles Enable Specific Binding of Apolipoproteins from Human Plasma.温度响应型纳米颗粒能够特异性结合人血浆中的载脂蛋白。
Small. 2022 Jan;18(3):e2103138. doi: 10.1002/smll.202103138. Epub 2021 Nov 10.
2
Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes.蛋白质冠层中的聚集素在纳米颗粒对吞噬细胞的隐身效应中起关键作用。
Biochem Biophys Res Commun. 2016 Nov 25;480(4):690-695. doi: 10.1016/j.bbrc.2016.10.121. Epub 2016 Oct 28.
3
Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.通过了解蛋白冠来控制纳米载体的隐身效应。
Angew Chem Int Ed Engl. 2016 Jul 25;55(31):8806-15. doi: 10.1002/anie.201602233. Epub 2016 Jun 15.
4
Coating nanoparticles with tunable surfactants facilitates control over the protein corona.用可调表面活性剂包覆纳米颗粒有助于控制蛋白质冠。
Biomaterials. 2017 Jan;115:1-8. doi: 10.1016/j.biomaterials.2016.11.015. Epub 2016 Nov 15.
5
How Low Can You Go? Low Densities of Poly(ethylene glycol) Surfactants Attract Stealth Proteins.你能降低到多低?低浓度的聚乙二醇表面活性剂能吸引隐形蛋白。
Macromol Biosci. 2018 Sep;18(9):e1800075. doi: 10.1002/mabi.201800075. Epub 2018 Jun 25.
6
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.蛋白质吸附是聚乙二醇-和聚磷酸酯-涂层纳米载体实现隐形效果所必需的。
Nat Nanotechnol. 2016 Apr;11(4):372-7. doi: 10.1038/nnano.2015.330. Epub 2016 Feb 15.
7
Poly (N-vinylpyrrolidone) modification mitigates plasma protein corona formation on phosphomolybdate-based nanoparticles.聚(N-乙烯基吡咯烷酮)修饰减轻了基于磷钼酸盐的纳米颗粒表面的血浆蛋白冠形成。
J Nanobiotechnology. 2021 Dec 23;19(1):445. doi: 10.1186/s12951-021-01140-8.
8
Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.纳米颗粒尺寸和聚乙二醇化对 PLGA 纳米颗粒蛋白质冠的影响。
Eur J Pharm Biopharm. 2019 Aug;141:70-80. doi: 10.1016/j.ejpb.2019.05.006. Epub 2019 May 10.
9
Denaturation via Surfactants Changes Composition of Protein Corona.通过表面活性剂使蛋白质冠变性会改变其组成。
Biomacromolecules. 2018 Jul 9;19(7):2657-2664. doi: 10.1021/acs.biomac.8b00278. Epub 2018 Apr 20.
10
Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.基于碳水化合物的纳米载体,具有特定的细胞靶向性,受蛋白冠的影响最小。
Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7436-40. doi: 10.1002/anie.201502398. Epub 2015 May 4.

引用本文的文献

1
Engineered protein corona sustains stealth functionality of nanocarriers in plasma.工程化蛋白质冠层维持纳米载体在血浆中的隐身功能。
J Nanobiotechnology. 2025 Jul 14;23(1):512. doi: 10.1186/s12951-025-03565-x.
2
Designing Dual-Responsive Drug Delivery Systems: The Role of Phase Change Materials and Metal-Organic Frameworks.设计双响应药物递送系统:相变材料和金属有机框架的作用。
Materials (Basel). 2024 Jun 22;17(13):3070. doi: 10.3390/ma17133070.
3
Protein Corona Composition of Gold Nanocatalysts.金纳米催化剂的蛋白质冠层组成
ACS Pharmacol Transl Sci. 2024 Mar 14;7(4):1169-1177. doi: 10.1021/acsptsci.4c00028. eCollection 2024 Apr 12.
4
Engineering Temperature-Responsive Polymer Nanoparticles that Load and Release Paclitaxel, a Low-Molecular-Weight Anticancer Drug.工程化温度响应性聚合物纳米颗粒,用于负载和释放低分子量抗癌药物紫杉醇。
ACS Omega. 2023 Dec 27;9(1):1011-1019. doi: 10.1021/acsomega.3c07226. eCollection 2024 Jan 9.
5
Uptake of extracellular vesicles into immune cells is enhanced by the protein corona.细胞外囊泡被蛋白冠增强后被免疫细胞摄取。
J Extracell Vesicles. 2023 Dec;12(12):e12399. doi: 10.1002/jev2.12399.
6
Current research trends of nanomedicines.纳米药物的当前研究趋势。
Acta Pharm Sin B. 2023 Nov;13(11):4391-4416. doi: 10.1016/j.apsb.2023.05.018. Epub 2023 May 20.
7
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System.纳米颗粒的生物学特性:蛋白质冠层的形成及其与免疫系统的相互作用。
Pharmaceutics. 2022 Nov 26;14(12):2605. doi: 10.3390/pharmaceutics14122605.
8
Harnessing Protein Corona for Biomimetic Nanomedicine Design.利用蛋白质冠层进行仿生纳米药物设计。
Biomimetics (Basel). 2022 Sep 6;7(3):126. doi: 10.3390/biomimetics7030126.